NCT00558818View on ClinicalTrials.gov

Long-term Study With Clevudine

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Chronic Hepatitis B
Interventions
DRUG

Clevudine

clevudine 30 mg qd

Trial Locations (1)

Unknown

KoreaUniversity Guro Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Bukwang Pharmaceutical

INDUSTRY

NCT00558818 - Long-term Study With Clevudine | Biotech Hunter | Biotech Hunter